Progress Treating Disease

Research does not end once a medicine is approved by the U.S. Food and Drug Administration; it is built upon to improve outcomes for patients, simplify treatment regimens and monitor safety. America’s biopharmaceutical research companies are committed to a dynamic research ecosystem that delivers safe and efficacious treatments to patients. Explore how far we’ve come in fighting disease.

Stopping the Spread of Ebola

Stopping the spread of Ebola will require close collaboration and engagement from stakeholders across the health care system, and the biopharmaceutical industry stands ready to do its part.

Read More

The Value of Cancer Treatment Today

In recent decades, tremendous progress has been made in the fight against cancer. Research has expanded our knowledge of how the disease develops and how to target medicine.

Read More

Fighting Disease | From Hope to Cures

From Our Network

America's biopharmaceutical research companies are developing new medicines that can prevent, cure, and treat diseases and improve patients' health.

Read More

Transforming the Treatment of High Cholesterol

Then & Now

The introduction of statin therapy nearly 30 years ago transformed the treatment of high cholesterol for many patients, yet some continued to face challenges.

Read More

Building on the Progress in Treating Diabetes

Then & Now

Expanded treatment options over the past decade have reduced barriers to patient compliance and helped patients better manage diabetes and enjoy a better quality of life.

Read More

Researching Melanoma: Progress Emerging From Years Of Setbacks

Article

Between 1998 and 2014, there were 96 unsuccessful drugs and 7 approved drugs for melanoma.

Read More

Great Moments in Treatment Innovation

Timeline

Innovative treatments have transformed the way we attack many devastating diseases. Learn more about the key advances that have changed medicine over the last century.

Read More

Delivering New Medicines to Patients

Graphic

America’s innovative biopharmaceutical companies are at the heart of a dynamic ecosystem.

Read More

Expanded Treatment Options for Multiple Sclerosis

Then & Now

Early and consistent treatment is crucial to successful management of multiple sclerosis (MS).

Read More

Clinical Trials in Your State

From Our Network

Discover the impact of industry-sponsored clinical trials in your state.

Read More

Advancing Science | From Hope to Cures

From Our Network

In an era of rapid scientific advancement, America’s biopharmaceutical researchers are working tirelessly to translate new findings into innovative treatments for patients.

Read More

Treatment Advances Transform HIV/AIDS

Timeline

New medicines, including combination treatments for HIV/AIDS, have transformed what was once a fatal diagnosis into a chronic disease for many patients.

Read More

Latest From TheBlog

Celebrating hope for patients and families on World Heart Day 2016

By Hannah Mooney on September 29, 2016 at 09:27 AM

4 recommendations for ICER

By Lauren Neves on September 26, 2016 at 03:17 PM

Medicare Monday: New Part D study highlights benefit of switching plans

By Allyson Funk on September 26, 2016 at 09:00 AM

340B Spotlight: Trends in shifting site of care

By Rachel Licata on September 21, 2016 at 09:30 AM